# Effect of Trimetazidine on Radiotherapy-induced Heart Damage.

> **NCT04939857** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Cardiotoxicity

## Interventions

- **DRUG:** Trimetazidine

## Key facts

- **NCT ID:** NCT04939857
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-25
- **Primary completion:** 2022-07-30
- **Final completion:** 2022-08-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04939857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04939857, "Effect of Trimetazidine on Radiotherapy-induced Heart Damage.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04939857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*